Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Towards host-directed therapies for tuberculosis

This article has been updated

Abstract

The treatment of tuberculosis is based on combinations of drugs that directly target Mycobacterium tuberculosis. A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Change history

  • 04 August 2015

    The spelling of Voahangy Rasolofo's name has been corrected.

References

  1. Zumla, A., Nahid, P. & Cole, S. T. Advances in the development of new tuberculosis drugs and treatment regimens. Nat. Rev. Drug Discov. 12, 388–404 (2013).

    CAS  Article  Google Scholar 

  2. Zumla, A. et al. Tuberculosis treatment and management — an update on treatment regimens, trials, new drugs, and adjunct therapies. Lancet Respir. Med. 3, 220–234 (2015).

    Article  Google Scholar 

  3. Wallis, R. S. & Hafner, R. Advancing host-directed therapy for tuberculosis. Nat. Rev. Immunol. 15, 255–263 (2015).

    CAS  Article  Google Scholar 

  4. Bento, C. F., Empadinhas, N. & Mendes, V. Autophagy in the fight against tuberculosis. DNA Cell Biol. 34, 228–242 (2015).

    CAS  Article  Google Scholar 

  5. Stanley, S. A. et al. Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth. PLoS Pathog. 10, e1003946 (2014).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Alimuddin Zumla or Markus Maeurer.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

Supplementary information

Supplementary information S1 (table)

Interventions under investigation as host-directed therapies for tuberculosis (PDF 282 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zumla, A., Chakaya, J., Hoelscher, M. et al. Towards host-directed therapies for tuberculosis. Nat Rev Drug Discov 14, 511–512 (2015). https://doi.org/10.1038/nrd4696

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4696

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing